Growth Metrics

AVITA Medical (RCEL) Current Deferred Revenue (2022 - 2025)

AVITA Medical posted quarterly Current Deferred Revenue of $323000.0 for Q4 2025, down 9.52% year-on-year from $357000.0 in Q4 2024, and down 2.42% on a QoQ basis from $331000.0 in Q3 2025.

AVITA Medical (RCEL) has 4 years of Current Deferred Revenue data on file, last reported at $323000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 9.52% year-over-year to $323000.0; the trailing twelve-month figure through Dec 2025 stood at $323000.0 (down 9.52% YoY), and the FY2025 full-year result was $323000.0, down 9.52% from the prior year.
  • Current Deferred Revenue for Q4 2025 stood at $323000.0, down from $331000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $698000.0 in Q4 2022 and bottomed at $205000.0 in Q2 2024.
  • The 4-year median for Current Deferred Revenue is $365000.0 (2024), against an average of $414000.0.
  • The widest annual swing landed in 2024, when Current Deferred Revenue plunged 63.2%; it then soared 65.85% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $698000.0 in 2022, then plunged by 44.13% to $390000.0 in 2023, then declined by 8.46% to $357000.0 in 2024, then retreated by 9.52% to $323000.0 in 2025.
  • The last three Current Deferred Revenue figures came in at $323000.0 (Q4 2025), $331000.0 (Q3 2025), and $340000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 AVITA Medical 121.89 Mn 103.71 Mn 14.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 323,000.00
Sep 30, 2025 331,000.00
Jun 30, 2025 340,000.00
Mar 31, 2025 348,000.00
Dec 31, 2024 357,000.00
Sep 30, 2024 365,000.00
Jun 30, 2024 205,000.00
Mar 31, 2024 382,000.00
Dec 31, 2023 390,000.00
Sep 30, 2023 469,000.00
Jun 30, 2023 557,000.00
Mar 31, 2023 617,000.00
Dec 31, 2022 698,000.00